Literature DB >> 16880241

Primary (AL) amyloidosis in plasma cell disorders.

Antonia M S Müller1, Annette Geibel, Hartmut P H Neumann, Alexander Kühnemund, Annette Schmitt-Gräff, Joachim Böhm, Monika Engelhardt.   

Abstract

Primary (AL) amyloidosis is the most common form of systemic amyloidosis. The morbidity arises from extracellular deposition of immunoglobulin light chain (LC) fibrils in major organs, such as the kidneys, heart, and bowel. Organ dysfunction contributes to a high mortality and poor prognosis, with a median survival time of 1-2 years from diagnosis. Here, we present a 46-year-old man with an exceptional clinical course of an LC multiple myeloma with generalized amyloidosis, causing renal insufficiency, congestive heart failure, and complete intestinal necrosis. We have summarized recent knowledge on AL amyloidosis, its association with monoclonal gammopathies, clinical presentations, diagnostic tools, and treatment strategies. Our comprehensive overview of this rare and often fatal disease aims to increase the awareness of AL amyloidosis. This may facilitate earlier diagnosis, and thus allow initiation of prompt and specific therapies, which are indispensable in order to improve disease prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880241     DOI: 10.1634/theoncologist.11-7-824

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  8 in total

1.  [A 65-year-old female patient with gastric outlet obstruction of unknown origin].

Authors:  N A Böhm; R Hamacher; S Schulz; J Gaa
Journal:  Radiologe       Date:  2009-07       Impact factor: 0.635

2.  Monoclonal gammopathy of renal significance: systemic involvement by benign condition.

Authors:  Vincenzo L'Imperio; Paolo Fabbrini; Franco Ferrario; Federico Pieruzzi; Antonella Tosoni; Rinaldo Brivio; Enrico Maria Pogliani; Fabio Pagni
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

3.  Site-directed mutagenesis reveals regions implicated in the stability and fiber formation of human λ3r light chains.

Authors:  Miryam I Villalba; Juan C Canul-Tec; Oscar D Luna-Martínez; Rosalba Sánchez-Alcalá; Timoteo Olamendi-Portugal; Enrique Rudiño-Piñera; Sonia Rojas; Rosana Sánchez-López; Daniel A Fernández-Velasco; Baltazar Becerril
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

Review 4.  Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.

Authors:  Adriana Zingone; W Michael Kuehl
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

5.  State-of-the-Art Management of Complications of Myeloma and Its Treatment.

Authors:  Monique A Hartley-Brown; Daniel M Sullivan; Rachid Baz
Journal:  Adv Hematol       Date:  2010-06-27

Review 6.  Comprehensive review on cardio-oncology: Role of multimodality imaging.

Authors:  Carol Chen-Scarabelli; Chad McRee; Massoud A Leesar; Fadi G Hage; Tiziano M Scarabelli
Journal:  J Nucl Cardiol       Date:  2016-05-25       Impact factor: 5.952

7.  Lymphedema Associated With Primary Amyloidosis: A Case Study.

Authors:  Gahee Park; Hye Won Jeong; Junhee Lee; Yeung-Chul Mun; Sun Hee Sung; Soo Jeong Han
Journal:  Ann Rehabil Med       Date:  2017-10-31

8.  Crystalglobulinemia manifesting as chronic arthralgia and acute limb ischemia: A clinical case report.

Authors:  Nobuya Abe; Tomoko Tomita; Miyuki Bohgaki; Hideki Kasahara; Takao Koike
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.